|
Andrew Woo, MD, PhD
Assistant Clinical Professor of Neurology
David Geffen School of Medicine at UCLA
Santa Monica Neurological Consultants
|
|
James Kenney, RPh, MBA
Founder
JTKenney, LLC.
|
|
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC.
|
|
Kyle Pinion
Senior Director of Education, Healthcare Relations & Advocacy
Multiple Sclerosis Association of America
|
|
TARGET AUDIENCE
|
- Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors and specialty pharmacists
- Pharmacy directors, registered nurses, quality directors, care managers, and other managed care and payer organization professionals
|
|
PROGRAM OVERVIEW
|
The purpose of this webcast is to enhance the collaboration between managed care decision makers and multiple sclerosis (MS) specialists with the goal of improving the overall quality of care for patients with MS. We hope to reach this goal by bridging gaps in communication between managed care decision makers and these specialists, creating a dialogue, and allowing both groups to share their views on coverage decisions for MS patients.
|
|
EDUCATIONAL OBJECTIVES
|
After completing the activity, participants should be better able to:
- Identify the clinic-economic impact of multiple sclerosis (MS)
- Review the safety, efficacy of current and emerging MS therapies
- Discuss the evolving advocacy and policy landscape impacting patients with MS
- Explore utilization management and benefit design strategies for MS therapies to promote appropriate prescribing and enhance outcomes
|
|
AGENDA
|
Opening Comments/Overview
James Kenney, RPh, MBA
|
Clinical Update and Economic Impact of MS
Andrew Woo, MD, PhD
|
Evolving Advocacy and Policy Landscape Impacting Patients with MS
Edmund Pezalla, MD, MPH
|
Medical and Pharmacy Management Strategies to Enhance MS Patient Outcomes
James Kenney, RPh, MBA
|
MSAA Overview
Kyle Pinion
|
Audience Question and Answer Session
Key Takeaways and Closing Comments
|
|
|
ACCREDITATION INFORMATION
|
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Credit
 |
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0816-9999-19-176-L01-P
This activity is certified as Knowledge-based CPE.
|
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
| Name of Faculty |
Reported Financial Relationships |
| James Kenney, RPh, MBA |
No financial interest/relationships relating to the topic of this activity |
| Edmund Pezalla, MD, MPH |
No financial interest/relationships relating to the topic of this activity |
| Andrew Woo, MD, PhD |
Speakers' Bureau - Genentech, Novartis, Sanofi-Genzyme, EMD Serono |
|
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
| Name of Content Manager |
Reported Financial Relationships |
| Impact Education, LLC. Content Managers |
No financial interest/relationships relating to the topic of this activity |
| MER Content Managers |
No financial interest/relationships relating to the topic of this activity |
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.
Fee Information
There is no fee for this educational activity.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
|
| |
